Hengrui Pharma Reports 88.9% Rise in Third-Quarter Profit
Hengrui Pharma reported an 88.9% rise in third-quarter 2026 profit, attributed in the headline to licensing deals.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Hengrui Pharma reported an 88.9% rise in third-quarter 2026 profit, attributed in the headline to licensing deals.